Preferred Label : guanfacine;
MeSH definition : A centrally acting antihypertensive agent with specificity towards ADRENERGIC ALPHA-2
RECEPTORS.;
MeSH hyponym : tenex; BS-100-141; Lon798; guanfacine hydrochloride; estulic; Hydrochloride, Guanfacine; Guanfacine Monohydrochloride; Monohydrochloride, Guanfacine; BS 100 141; BS100141;
MeSH CAS label : benzeneacetamide, N-(aminoiminomethyl)-2,6-dichloro-;
MeSH Related Number : guanfacine hydrochloride; 29110-47-2 (Guanfacine); 29110-48-3 (Guanfacine hydrochloride); PML56A160O;
Registry Number MeSH : 29110-47-2;
Related CAS MeSH : PML56A160O (Guanfacine hydrochloride);
Wikipedia link : https://en.wikipedia.org/wiki/Guanfacine;
Codes EINECS : 249-442-8;
Is substance : O;
UNII : 30OMY4G3MK;
InChIKey : INJOMKTZOLKMBF-UHFFFAOYSA-N;
Origin ID : D016316;
UMLS CUI : C0079466;
ATC code(s)
Allowable qualifiers
CISMeF manual mappings
Pharmacological action(s)
Record concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
A centrally acting antihypertensive agent with specificity towards ADRENERGIC ALPHA-2
RECEPTORS.
https://www.ema.europa.eu/en/medicines/human/EPAR/paxneury
2025
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
guanfacine
guanfacine
attention deficit disorder with hyperactivity
child
adolescent
Attention deficit disorder of childhood without mention of hyperactivity
drugs, generic
continuity of patient care
administration, oral
tablets
Product containing only guanfacine in oral dose form (medicinal product form)
guanfacine hydrochloride
guanfacine hydrochloride
Delayed-Action preparations
Product containing precisely guanfacine (as guanfacine hydrochloride) 1 milligram/1
each prolonged-release oral tablet (clinical drug)
Product containing precisely guanfacine (as guanfacine hydrochloride) 2 milligram/1
each prolonged-release oral tablet (clinical drug)
Product containing precisely guanfacine (as guanfacine hydrochloride) 3 milligram/1
each prolonged-release oral tablet (clinical drug)
Product containing precisely guanfacine (as guanfacine hydrochloride) 4 milligram/1
each prolonged-release oral tablet (clinical drug)
drug monitoring
product surveillance, postmarketing
drug interactions
drug evaluation, preclinical
receptor, adrenergic, alpha-2A
Alpha-2 adrenergic receptor agonist (disposition)
---
https://www.has-sante.fr/portail/jcms/c_2769369/fr/intuniv
https://www.has-sante.fr/portail/jcms/c_2769369/fr/intuniv-guanfacine-agoniste-alpha-adrenergique
2017
false
false
false
France
French
treatment outcome
guanfacine
guanfacine
child
adolescent
attention deficit disorder with hyperactivity
continuity of patient care
administration, oral
Delayed-Action preparations
adrenergic alpha-2 receptor agonists
Guanfacine hydrochloride 4mg extended release tablet (product)
Guanfacine hydrochloride 1mg extended release tablet (product)
Guanfacine hydrochloride 3mg extended release tablet (product)
Guanfacine hydrochloride 2mg extended release tablet (product)
evaluation of the transparency committee
guidelines for drug use
---
https://www.hc-sc.gc.ca/dhp-mps/medeff/bulletin/hpiw-ivps_2016-10-fra.php#a21
2016
false
false
false
Canada
French
pharmacovigilance note
guanfacine
---
https://www.ema.europa.eu/medicines/human/EPAR/Intuniv
2015
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
guanfacine
guanfacine
guanfacine
child
adolescent
attention deficit disorder with hyperactivity
continuity of patient care
administration, oral
drug monitoring
product surveillance, postmarketing
Delayed-Action preparations
drug interactions
pregnancy
breast feeding
adrenergic alpha-2 receptor agonists
adrenergic alpha-2 receptor agonists
drug evaluation, preclinical
Guanfacine hydrochloride 4mg extended release tablet (product)
Guanfacine hydrochloride 1mg extended release tablet (product)
Guanfacine hydrochloride 3mg extended release tablet (product)
Guanfacine hydrochloride 2mg extended release tablet (product)
---
https://www.inspq.qc.ca/toxicologie-clinique/la-guanfacine-un-medicament-non-psychostimulant-autorise-pour-le-traitement-du-trouble-deficitaire-de-l-attention-avec-ou-sans-hyperactivite
2015
false
true
false
Canada
French
journal article
attention deficit and disruptive behavior disorders
guanfacine
guanfacine
guanfacine
attention deficit disorder with hyperactivity
guanfacine
---
http://www.lecrat.eu/?s=Guanfacine
2011
France
drug information
guanfacine
---